{"page_content": " \n \nZealand Pharma A/ S Statutory report on Corporate Social Responsibility 2016  11/11 \nbetween those who are listed on its permanent insiders\u2019 lis t and those who are exposed to  what is \ndeemed insider  information. In the latter case, Zealand takes every precaution to keep an up -to-date list \nof employees\u2019 knowledge of insider information. All new employees are introduced to our internal rules \nand have  to sign a document stipulating that they have read and understood these rules.  \n \nIntellectual property  \nThe Company has strict policies regarding the proper use and transfer of intellectual property. Since it \nwas founded, Zealand has refined its confident iality and material transfer agreements to reflect critical \nchanges in the industry, building on the extensive industry experience of many of its senior members.  \n \nAchievements in 2016  \n \n\u2022 No issues were reported in 2016 under our whistleblower program (2015:  0). \n\u2022 Zealand has no knowledge  of any violations of the above categories (2015: 0).  \n \nFocus areas in 2017  \n \n\u2022 Zealand will continue to operate  according to the highest ethical standard s.  \n \n ", "metadata": {"source": "NASDAQ_ZEAL_2016.pdf", "page": 10, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}